Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 25, 2025 03:10 ET | Source: Karolinska Development AB (publ)

Karolinska Developments portföljbolag AnaCardio inkluderar den första patienten i en fas 2a-studie med läkemedelskandidaten AC01

STOCKHOLM, SVERIGE 25 februari 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att portföljbolaget AnaCardio har doserat den första patienten i den andra delen av den kliniska...
February 25, 2025 03:10 ET | Source: Karolinska Development AB (publ)

Karolinska Development’s portfolio company AnaCardio includes first patient in a phase 2a study of its drug candidate AC01

STOCKHOLM, SWEDEN February 25, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company AnaCardio has dosed the first patient in the phase 2a part of the...
February 18, 2025 08:17 ET | Source: Karolinska Development AB (publ)

Karolinska Developments portföljbolag Promimic publicerar positiva resultat som visar reducerad bakterietillväxt på HAnano Surface

STOCKHOLM, SVERIGE 18 februari 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att portföljbolaget Promimic har publicerat positiva resultat som visar en reduktion av...
February 18, 2025 08:17 ET | Source: Karolinska Development AB (publ)

Karolinska Developments portfolio company Promimic publishes positive results on reduction of bacteria growth on HAnano Surface

STOCKHOLM, SWEDEN, February 18 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Promimic has published positive results showing a reduction of...
February 14, 2025 02:00 ET | Source: Karolinska Development AB (publ)

Bokslutskommuniké för januari – december 2024

STOCKHOLM – den 14 februari 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) publicerar idag sin bokslutskommuniké för januari – december 2024. Den fulla rapporten är tillgänglig på bolagets...
February 14, 2025 02:00 ET | Source: Karolinska Development AB (publ)

Year-end Report - January-December 2024

STOCKHOLM – 14 February 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today publishes its Year-end Report January-December 2024. The full report is available on the Company's website. ...
January 30, 2025 02:50 ET | Source: Karolinska Development AB (publ)

Karolinska Developments portföljbolag Dilafor avancerar tafoxiparin efter framgångsrika möten med FDA och europeiska läkemedelsmyndigheter

STOCKHOLM, SVERIGE 30 januari 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att portföljbolaget Dilafor framgångsrikt genomfört rådgivande möten med den amerikanska...
January 30, 2025 02:50 ET | Source: Karolinska Development AB (publ)

Karolinska Development’s portfolio company Dilafor advances tafoxiparin following successful meetings with FDA and European regulatory authorities

STOCKHOLM, SWEDEN – January 30, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Dilafor has successfully completed regulatory meetings with the U.S....
January 09, 2025 05:50 ET | Source: Karolinska Development AB (publ)

Karolinska Developments portföljbolag AnaCardio säkrar SEK 205 miljoner i ny finansiering och presenterar positiva fas 1b-data för AC01

STOCKHOLM, SVERIGE 9 januari 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att portföljbolaget AnaCardio har säkrat finansiering om SEK 205 miljoner i en utökad serie...
January 09, 2025 05:50 ET | Source: Karolinska Development AB (publ)

Karolinska Development’s portfolio company AnaCardio raises SEK 205 million and reports positive Phase 1b data of AC01

STOCKHOLM, SWEDEN January 9, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company AnaCardio has secured SEK 205 million in a series A extension financing...